CD4 and cancer: Interestingly, although the negative regulatory trend was depicted in most cancers, we observed positive regulation of M1 macrophages and CD8+ T cells functioning as antitumor roles as well as negative regulation of CD4+ T cells and MDSCs (served as tumor-promoting roles including M2 macrophage, DC, and neutrophil) in some tumors.